PDA for Kidneys Study

Description

The goal of this observational study is to gather more information on kidney oxygen levels in babies with a patent ductus arteriosus (PDA), and evaluate the relationships between kidney oxygen levels, PDA status and kidney injury. Researchers will do this by looking at ultrasound images of the heart, analyzing substances in the urine, and evaluating oxygen levels in the kidneys.

Conditions

Patent Ductus Arteriosus, Congenital Heart Disease

Talk to us

Study Overview

On this page

Study Details

Study overview

The goal of this observational study is to gather more information on kidney oxygen levels in babies with a patent ductus arteriosus (PDA), and evaluate the relationships between kidney oxygen levels, PDA status and kidney injury. Researchers will do this by looking at ultrasound images of the heart, analyzing substances in the urine, and evaluating oxygen levels in the kidneys.

Development of a Novel Kidney-focused Approach to Treatment of a Patent Ductus Arteriosus (PDA) in Vulnerable Preterm Neonates - A Pilot Study

PDA for Kidneys Study

Condition
Patent Ductus Arteriosus
Intervention / Treatment

-

Contacts and Locations

Madison

Meriter Hospital, Inc., Madison, Wisconsin, United States, 53715

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Delivered at \<32 weeks' gestation
  • * ≤72 hours of age
  • * Inpatient at Meriter Hospital, Inc. NICU
  • * At least one parent/guardian is able to provide parental permission in English or Spanish
  • * Major congenital anomalies of kidney
  • * Attending physician's discretion to not place NIRS sensors due to clinical concerns
  • * In the PI or Co-I's medical opinion, there is a significant likelihood that the neonate would not survive the first 3 days of life
  • * Birth parent aged \<18

Ages Eligible for Study

1 Minute to 7 Days

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of Wisconsin, Madison,

Matthew Harer, MD, PRINCIPAL_INVESTIGATOR, University of Wisconsin, Madison

Study Record Dates

2025-06